virus
use
varieti
mechan
dampen
host
gene
express
includ
inhibit
capdepend
translat
transcript
splice
promot
host
mrna
degrad
presum
viral
benefit
host
shutoff
phenotyp
includ
reduc
competit
gene
express
machineri
resourc
well
impair
immun
respons
decreas
host
factor
involv
sens
infect
import
phenotyp
vivo
directli
confirm
alpha
gammaherpesvirus
host
shutoff
mutant
exhibit
defect
immun
evas
case
herp
simplex
virus
viral
traffick
latenc
establish
case
studi
date
viral
transcript
larg
escap
effect
host
shutoff
thu
afford
competit
express
advantag
exampl
polioviru
inhibit
capdepend
translat
cleav
thu
enhanc
translat
viral
mrna
contain
intern
ribosom
entri
site
ire
cap
one
mechan
hsvinduc
host
shutoff
involv
alter
phosphoryl
sr
protein
inhibit
spliceosom
assembl
block
biogenesi
nascent
host
mrna
vast
major
contain
intron
contrast
hsv
mrna
larg
unsplic
enabl
circumv
block
furthermor
preferenti
export
cytoplasm
protein
also
promot
endonucleolyt
cleavag
host
mrna
viral
encod
ribonucleas
vh
packag
viral
particl
thu
impact
host
gene
express
immedi
viral
entri
although
mrna
degrad
vh
absenc
infect
recent
data
suggest
vh
regul
viral
factor
manner
restrict
activ
viral
rna
particularli
delay
earli
late
gene
express
sar
coronaviru
also
caus
host
shutoff
promot
endonucleolyt
cleavag
cellular
mrna
viral
mrna
bear
protect
leader
sequenc
prevent
cleavag
similar
alphaherpesvirus
sar
coronaviru
gammaherpesvirus
promot
host
shutoff
induc
widespread
cellular
mrna
degrad
viral
subfamili
includ
oncogen
human
pathogen
kaposi
sarcomaassoci
herpesviru
kshv
epsteinbarr
viru
ebv
well
murin
herpesviru
wide
use
model
understand
gammaherpesvir
replic
pathogenesi
vivo
gammaherpesvirus
encod
viral
nucleas
term
sox
kshv
endonucleolyt
cleav
cytoplasm
mrna
lytic
infect
lead
degrad
host
exoribonucleas
sox
target
major
host
mrna
ensu
deplet
cytoplasm
poli
mrna
caus
nuclear
reloc
cytoplasm
poli
bind
protein
pabpc
aberr
polyadenyl
rna
nucleu
mrna
export
defect
downstream
phenotyp
effect
magnifi
gene
express
block
global
mrna
destruct
mechanist
conserv
sox
homolog
ebv
term
term
musox
pabpc
reloc
rna
process
export
sequela
activ
like
contribut
viral
immun
evas
shown
rna
degrad
function
ebv
impair
cell
recognit
cultur
cell
addit
bear
musox
mutant
specif
defect
mrna
cleavag
exhibit
vivo
defect
viral
traffick
mous
lung
distal
site
well
mark
reduct
viral
load
peak
latenc
establish
thu
widespread
mrna
degrad
lytic
replic
gammaherpesvirus
contribut
measur
vivo
viral
lifecycl
well
interact
host
immun
system
prevail
assumpt
host
mrna
degrad
driver
phenotyp
similar
virus
studi
date
viral
transcript
must
possess
mechan
escap
degrad
howev
suscept
viral
transcript
soxinduc
cleavag
infect
yet
directli
address
although
possess
common
sequenc
might
aid
escap
sox
musox
express
earli
gene
kinet
begin
hour
post
infect
hpi
continu
end
viral
lifecycl
therefor
presum
minimum
viral
gene
express
prior
onset
host
shutoff
would
unaffect
sox
musox
activ
challeng
assumpt
show
unexpectedli
stage
viral
gene
express
strongli
influenc
musoxinduc
rna
degrad
infect
major
viral
mrna
target
musox
lytic
infect
wherea
escape
enrich
viral
noncod
rna
decreas
viral
mrna
level
wildtyp
infect
dampen
viral
protein
accumul
directli
influenc
composit
progeni
viral
particl
turn
impact
earli
event
subsequ
round
infect
prior
onset
host
shutoff
final
demonstr
inhibit
global
viru
host
mrna
degrad
restrict
replic
cell
type
specif
manner
cell
cultur
vivo
find
reveal
new
layer
complex
underli
gammaherpesviru
gene
express
control
highlight
import
mrna
degrad
viral
life
cycl
gammaherpesvir
sox
protein
drive
widespread
degrad
cellular
mrna
lytic
infect
yet
extent
viral
transcript
escap
fate
remain
unknown
address
question
compar
mutant
impair
host
shutoff
host
shutoff
defect
match
mutant
rescu
mr
viru
mutat
restor
wild
type
contain
mutat
locat
gene
encod
sox
homolog
musox
render
musox
select
defect
mrna
degrad
viral
transcript
abund
comprehens
evalu
use
microarray
platform
contain
tile
probe
provid
coverag
strand
viral
genom
rel
transcript
level
measur
nih
cell
infect
moi
hour
post
infect
hpi
time
mrna
degrad
phenotyp
well
establish
surprisingli
major
viral
mrna
three
kinet
class
immedi
earli
ie
earli
e
late
l
significantli
downregul
mr
infect
compar
infect
suggest
viral
transcript
broadli
escap
musoxinduc
degrad
figur
red
bar
trend
confirm
use
rtqpcr
independ
measur
viral
mrna
level
infect
three
repres
gene
orf
normal
host
shutoff
resist
ribosom
rna
furthermor
rtqpcr
analysi
sever
gene
appear
unchang
array
data
orf
indic
also
decreas
infect
mr
rel
suggest
microarray
result
may
underestim
extent
viral
mrna
target
musox
figur
rtqpcr
analysi
transcript
murin
dendrit
cell
line
primari
murin
embryon
fibroblast
mef
infect
mr
viru
yield
similar
result
indic
musox
target
viral
transcript
infect
occur
multipl
cell
type
figur
reduc
viral
transcript
level
could
either
due
cleavag
viral
mrna
musox
secondari
consequ
alter
level
cellular
protein
eg
transcript
factor
affect
host
shutoff
distinguish
possibl
compar
halflif
repres
ie
e
orf
l
viral
transcript
follow
infect
cell
mr
viru
decay
rate
mrna
calcul
follow
addit
actinomycin
actd
halt
transcript
hpi
case
mutat
led
signific
increas
transcript
stabil
indic
directli
target
degrad
musox
figur
thu
host
shutoff
restrict
cellular
mrna
also
broadli
impact
viral
mrna
abund
gammaherpesviru
infect
although
major
transcript
appear
subject
degrad
host
shutoff
subset
may
escap
fate
figur
green
bar
exampl
level
mrna
higher
mr
infect
cell
rel
infect
measur
microarray
analysi
rtqpcr
figur
interestingli
mani
put
escape
candid
confirm
noncod
rna
ncrna
inde
analysi
viral
mrna
ncrna
distribut
reveal
viral
mrna
fall
musoxsuscept
categori
wherea
popul
musox
escape
strongli
enrich
ncrna
figur
observ
correl
well
previou
data
indic
gammaherpesvir
sox
protein
preferenti
target
translat
compet
cellular
mrna
confirm
noncod
transcript
deplet
musox
compar
abund
seven
rna
polymeras
iii
pol
iii
transcrib
viral
trna
infect
mr
viru
hpi
rtqpcr
figur
contrast
viral
mrna
none
trna
level
decreas
mr
infect
rel
infect
viru
next
examin
sever
express
genom
region
egr
rna
polymeras
ii
pol
ii
transcript
distribut
throughout
genom
lack
appar
code
capac
similar
viral
trna
accord
microarray
data
qpcr
analysi
indic
sever
egr
escap
downregul
musox
find
confirm
halflif
analysi
egr
figur
egr
modestli
markedli
upregul
mr
infect
though
due
secondari
transcript
increas
rather
enhanc
rna
stabil
data
shown
note
egr
escap
effect
host
shutoff
egr
decreas
mr
rel
infect
figur
given
egr
yet
function
character
possibl
decreas
presenc
activ
musox
truli
noncod
may
possess
certain
mrnalik
featur
collect
howev
data
suggest
musox
preferenti
target
viral
mrna
degrad
mani
viral
ncrna
unaffect
upregul
host
shutoff
reason
musoxinduc
deplet
viral
mrna
import
regul
viral
gene
express
differ
mrna
level
lead
correspond
alter
viral
protein
abund
protein
level
therefor
measur
viral
factor
avail
antibodi
western
blot
lysat
nih
cell
infect
mr
inde
accord
mrna
abund
data
infect
cell
contain
higher
protein
level
gb
musox
vcyclin
rel
cell
infect
mr
viru
figur
mrna
abund
chang
result
alter
protein
level
howev
protein
accumul
similar
level
mr
infect
even
though
transcript
target
musox
result
indic
case
musox
target
viral
mrna
regul
protein
abund
mr
infect
might
broad
musoxdriven
reduct
viral
gene
express
impact
outcom
infect
one
possibl
increas
abund
select
viral
protein
absenc
function
musox
might
lead
alter
viral
particl
composit
exampl
elev
concentr
envelop
tegument
protein
particular
shown
tegument
composit
influenc
intracellular
protein
concentr
therefor
analyz
composit
virion
purifi
mr
infect
cell
mass
spectrometri
ms
figur
show
rel
abund
protein
detect
mr
virion
two
ms
run
sever
protein
detect
sampl
thu
exclud
compar
analysi
full
list
ms
result
provid
tabl
ensur
differ
due
unequ
viral
particl
number
sampl
peptid
count
first
normal
major
capsid
protein
capsid
composit
geometr
constrain
thu
influenc
intracellular
protein
abund
perform
secondari
normal
genom
number
tabl
among
viral
protein
avail
comparison
increas
abund
select
tegument
orf
envelop
gb
protein
virion
rel
mr
virion
figur
expect
level
minor
capsid
protein
minor
scaffold
protein
remain
unchang
valid
normal
strategi
tegument
protein
appear
unchang
well
indic
compon
virion
alter
confirm
data
compar
abund
addit
virion
compon
detect
ms
purifi
viral
particl
resolv
sdspage
western
blot
antibodi
orf
inde
tegument
protein
glycoprotein
gb
accumul
higher
level
virion
figur
contrast
observ
differ
rel
abund
minor
capsid
protein
confirm
alter
virion
composit
absenc
host
shutoff
restrict
virion
deriv
cell
compar
level
musoximpact
tegument
protein
western
blot
virion
purifi
infect
mef
observ
similar
increas
level
viru
figur
thu
absenc
musoxinduc
mrna
degrad
abund
sever
viral
protein
increas
result
alter
composit
progeni
virion
next
sought
determin
whether
differ
mr
particl
result
function
distinct
de
novo
infect
given
viral
envelop
glycoprotein
involv
cell
surfac
bind
intern
hypothes
increas
glycoprotein
concentr
observ
gb
might
influenc
event
first
measur
viral
attach
nih
cell
dendrit
cell
line
incub
mr
min
allow
attach
prevent
uptak
measur
rel
level
attach
virion
qpcr
viral
genom
figur
inde
mark
fold
increas
viru
bind
rel
mr
bind
cell
type
figur
observ
similar
result
quantifi
viral
entri
incub
min
acid
strip
measur
intracellular
viral
particl
qpcr
indic
bound
particl
success
intern
figur
increas
bind
entri
virion
secondari
consequ
excess
defect
particl
observ
signific
differ
ratio
wt
mr
virus
figur
conclud
alter
virion
composit
directli
influenc
first
step
viral
lifecycl
next
examin
whether
alter
virion
composit
influenc
progress
lifecyl
post
entri
particular
tegument
protein
deposit
directli
newli
infect
cell
thu
pois
earli
impact
cours
infect
key
earli
outcom
herpesviru
infect
whether
incom
viru
establish
latenc
progress
lytic
replic
latenc
gener
favor
upon
gammaherpesviru
infect
vivo
cultur
cell
although
atyp
cell
cultur
unlik
vivo
default
lytic
replic
previous
observ
infect
cell
immedi
enter
lytic
cycl
larger
proport
nih
cell
display
lytic
marker
musox
upon
infect
viru
compar
mr
viru
determin
whether
enhanc
lytic
entri
phenotyp
specif
cell
repres
gener
effect
measur
proport
infect
cell
express
lytic
protein
nih
cell
mous
embryo
fibroblast
mef
hpi
figur
use
lytic
marker
level
influenc
musox
activ
see
figur
virus
constitut
express
gfp
serv
marker
infect
cell
inde
nih
mef
cell
respect
gfp
infect
cell
also
infect
viru
howev
nih
mef
cell
infect
mr
viru
doubl
posit
figur
thu
rna
degrad
musox
temper
viral
lytic
cycl
entri
de
novo
infect
hypothes
increas
number
infect
cell
directli
enter
lytic
cycl
might
consequ
enhanc
activ
rta
major
lytic
transactiv
although
rta
compon
particl
ie
gene
whose
activ
influenc
tegument
protein
repres
virion
figur
assess
rta
activ
earli
time
post
infect
measur
level
rtarespons
transcript
orf
rta
orf
orf
rtqpcr
figur
three
rtarespons
transcript
induc
significantli
higher
level
hpi
pvalu
infect
viru
compar
mr
viru
similar
trend
observ
hpi
although
differ
time
point
statist
signific
importantli
level
cellular
gapdh
mrna
remain
unchang
hpi
expect
decreas
hpi
host
shutoff
figur
gener
start
hpi
confirm
effect
viral
transcript
accumul
manifest
prior
onset
musoxinduc
mrna
degrad
therefor
must
deriv
differ
incom
viral
particl
thu
rta
activ
stimul
shortli
infect
viru
like
due
higher
level
rta
activ
within
virion
given
enhanc
viral
gene
express
lytic
cycl
entri
phenotyp
viru
might
predict
mutant
viru
would
replic
effici
observ
engin
constitut
express
rta
howev
shown
growth
advantag
mr
nih
cell
furthermor
mice
display
defect
traffick
lung
distal
site
well
sever
decreas
abund
splenocyt
week
post
infect
peak
latenc
establish
observ
suggest
may
cell
type
specif
replic
defect
associ
impair
musox
rna
degrad
activ
manifest
subsequ
viral
entri
gene
express
enhanc
observ
therefor
compar
replic
rate
mr
virus
nih
mef
cell
use
multistep
growth
curv
report
previous
mr
virus
grew
similar
titer
nih
cell
figur
howev
display
moder
delay
kinet
mef
cell
result
log
defect
dpi
figur
sever
delay
kinet
cell
result
log
defect
dpi
figur
result
notabl
given
infect
traffic
dendrit
cell
mice
thu
although
viru
bind
enter
cell
effici
mr
failur
control
gene
express
musox
activ
result
downstream
amplif
defect
b
cell
key
site
viral
replic
latenc
establish
vivo
howev
cell
readili
infect
cultur
therefor
sought
monitor
viral
replic
cell
infect
mice
infect
via
intraperiton
rout
ip
lead
lytic
replic
macrophag
b
cell
spleen
peak
dpi
whereupon
lytic
infect
cell
larg
clear
prior
onset
peak
latenc
dpi
therefor
measur
viral
load
splenocyt
mice
infect
ip
viru
dpi
lytic
replic
phase
found
significantli
reduc
viral
titer
compar
mr
figur
data
indic
inhibit
musoxinduc
rna
degrad
restrict
amplif
cell
type
specif
manner
vitro
vivo
find
demonstr
major
gammaherpesvir
mrna
target
musox
nucleas
thu
reveal
novel
layer
regul
viral
gene
express
import
activ
highlight
alter
virion
composit
well
viral
entri
earli
lytic
gene
induct
viral
amplif
manifest
absenc
function
musox
thu
control
viral
mrna
abund
enhanc
degrad
regulatori
activ
exert
influenc
throughout
viral
lifecycl
gammaherpesvir
strategi
distinct
host
shutoffinduc
virus
character
date
evolv
mechan
select
target
host
gene
express
even
compar
gammaherpesvirus
relat
alphaherpesvirus
also
induc
mrna
cleavag
sever
distinct
appar
regul
function
host
shutoff
activ
exampl
host
shutoff
factor
vh
packag
viral
particl
therefor
promot
rna
degrad
immedi
viral
entri
onset
viral
gene
express
propos
vhsinduc
degrad
immedi
earli
mrna
may
facilit
transit
immedi
earli
earli
viral
gene
express
howev
least
three
viral
protein
subsequ
interact
vh
restrict
activ
viral
transcript
express
earli
late
kinet
class
contrast
gammaherpesvir
sox
protein
packag
virion
express
earli
kinet
begin
hpi
global
mrna
degrad
occur
follow
sox
express
continu
remaind
viral
lifecycl
unlik
alphaherpesvirus
distinct
transit
kinet
class
viral
gene
gammaherpesviru
infect
onset
new
phase
coincid
downregul
prior
class
viral
gene
thu
musox
continu
accumul
even
final
stage
viral
replic
cycl
result
degrad
viral
transcript
earli
late
kinet
class
target
viral
cellular
mrna
musox
like
occur
via
similar
mechan
previous
shown
sox
homolog
preferenti
cleav
rna
transcrib
pol
ii
translat
compet
fail
degrad
rna
transcrib
rna
pol
iii
agreement
data
observ
similar
prefer
viral
mrna
ncrna
musox
target
particular
none
rna
pol
iii
transcrib
viral
trna
deplet
musox
clear
enrich
put
ncrna
egr
escape
popul
suscept
certain
egr
musox
may
reflect
differ
composit
presenc
small
orf
local
potenti
regulatori
activ
find
may
therefor
use
futur
studi
aim
probe
function
egr
though
major
viral
mrna
appear
target
musox
code
transcript
escap
deplet
also
observ
popul
cellular
mrna
presum
escap
either
lack
soxtarget
element
contain
specif
protect
featur
demonstr
recent
cellular
interleukin
transcript
select
viral
mrna
refractori
musoxinduc
turnov
may
exhibit
similar
divers
protect
featur
delin
precis
musoxtarget
rna
element
shed
light
issu
addit
whether
select
protect
impact
viral
replic
pathogenesi
remain
import
question
futur
studi
particularli
strike
find
musoxinduc
degrad
viral
mrna
influenc
event
occur
first
hpi
either
express
host
shutoff
initi
effect
manifest
consequ
alter
virion
composit
impos
prior
round
replic
evid
suggest
extens
proteinprotein
interact
dictat
tegument
composit
delet
certain
protein
alter
balanc
furthermor
pseudorabi
virion
lack
select
tegument
protein
accumul
actin
viral
particl
suggest
critic
mass
fill
relat
protein
abund
infect
cell
find
other
togeth
observ
indic
tegument
highli
orchestr
process
regul
specif
protein
interact
well
protein
abund
least
partial
control
level
viral
mrna
stabil
anticip
addit
protein
composit
chang
examin
herein
presum
increas
level
viral
perhap
cellular
mrna
packag
virion
may
also
impact
earli
event
viral
lifecycl
inde
previous
observ
rna
packag
herpesvir
particl
manner
larg
link
intracellular
abund
addit
potenti
structur
role
virion
tegument
protein
manipul
cellular
environ
immedi
releas
thu
thought
play
key
role
facilit
infect
exampl
immun
evas
partli
mediat
activ
kshv
homolog
inhibit
type
ifn
respons
well
downregul
mhcii
cell
surfac
tegument
protein
involv
augment
earli
viral
gene
express
hcmv
kshv
rta
act
lytic
transactiv
coordin
viral
cellular
factor
unlik
kshv
rta
packag
virion
although
express
immedi
earli
kinet
sever
tegument
protein
facilit
lytic
infect
boost
activ
exampl
interact
cellular
inhibitor
rta
degrad
pmlnb
interfer
lytic
cycl
progress
observ
cell
infect
viru
display
enhanc
rta
activ
shortli
infect
confirm
failur
moder
viral
protein
level
mrna
degrad
mark
consequ
subsequ
round
infect
includ
preferenti
enhanc
immedi
earli
lytic
gene
express
infect
varieti
cell
type
vitro
vari
outcom
includ
effici
lytic
replic
fibroblast
delay
lytic
entri
dendrit
cell
primarili
latent
abort
lytic
infect
macrophag
vivo
evid
suggest
epitheli
cell
lytic
infect
dendrit
cell
macrophag
b
cell
mainli
support
latenc
initi
burst
lytic
infect
amplifi
viru
seed
popul
infect
cell
previous
report
viru
exhibit
dramat
reduc
viral
load
dpi
peak
latenc
found
viru
also
exhibit
cell
type
specif
defect
lytic
amplif
stage
vivo
cultur
cell
thu
despit
enhanc
lytic
gene
express
phenotyp
viru
one
subsequ
step
replic
cycl
impair
certain
cell
type
though
basi
cell
autonom
replic
defect
remain
unknown
reduc
amplif
vivo
could
manifest
part
impair
immun
evas
exampl
consequ
elev
viral
antigen
level
abort
infect
one
possibl
innat
immun
sens
respons
mechan
differenti
tune
cell
type
specif
manner
failur
degrad
viral
host
mrna
trigger
robust
antivir
respons
certain
cell
type
addit
note
wt
lifecycl
progress
slowli
dendrit
cell
rel
cell
mef
unpublish
observ
perhap
make
cell
impact
increas
accumul
viral
mrna
infect
data
challeng
assumpt
virus
dampen
host
gene
express
categor
provid
competit
advantag
viral
gene
express
instead
reveal
degrad
viral
transcript
lytic
gammaherpesvir
infect
integr
establish
appropri
balanc
viral
factor
necessari
replic
optim
virion
composit
clearli
degrad
viral
mrna
absolut
mechan
may
exist
temper
effect
musox
ensur
adequ
accumul
viral
transcript
exampl
shown
kshv
stabil
viral
rna
nucleu
cytoplasm
addit
viral
mrna
may
contain
regulatori
sequenc
help
modul
stabil
deciph
mani
layer
gene
express
regul
coordin
infect
remain
import
futur
challeng
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
protocol
approv
committe
ethic
anim
experi
univers
california
berkeley
approv
number
anim
anesthet
prior
infect
isofluran
effort
made
minim
suffer
nih
nih
vero
mef
cell
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
fetal
bovin
serum
fb
invitrogen
green
fluoresc
protein
gfp
express
bacteri
artifici
chromosom
bac
describ
elsewher
host
shutoff
mutant
previous
gener
allel
exchang
previous
describ
bacderiv
viru
produc
transfect
bac
dna
nih
cell
use
superfect
qiagen
viru
amplifi
nih
cell
titer
plaqu
assay
nih
cell
infect
mice
loxpflank
bac
vector
sequenc
remov
passag
viru
vero
cell
express
cre
recombinas
kindli
provid
dr
samuel
speck
emori
univers
array
data
deriv
two
independ
biolog
replic
infect
condit
custom
tile
array
format
design
describ
previous
rna
revers
transcrib
use
oligo
dt
promoterprim
subject
linear
amplif
label
use
agil
quick
amp
label
kit
adenoviru
spikein
control
ad
label
reaction
allow
normal
per
twocolor
spikein
kit
instruct
agil
refer
rna
deriv
independ
infect
nih
cell
hpi
wt
gener
purifi
fragment
hybrid
parallel
sampl
rna
h
microarray
scan
agil
scanner
control
softwar
version
hybrid
signal
intens
quantifi
use
agil
featur
extract
softwar
version
raw
data
process
subtract
median
background
signal
mean
signal
agil
featur
extract
file
normal
multipli
valu
probe
intens
spikein
scale
factor
array
scale
factor
calcul
linear
fit
spikein
versu
concentr
normal
refer
rna
signal
subtract
normal
experiment
sampl
rna
signal
probe
express
valu
viral
orf
calcul
median
normal
signal
tile
probe
enclos
insid
orf
qualiti
control
analys
indic
strong
correl
biolog
replic
figur
differenti
express
gene
identifi
perform
empir
bay
moder
tstatist
use
bioconductor
limma
packag
version
rna
isol
use
zymo
mini
rna
ii
isol
kit
zymo
research
treat
turbo
dnase
ambion
remov
genom
dna
contamin
revers
transcrib
use
amv
rt
promega
oligo
dt
specif
primer
ncrna
analysi
transcript
specif
revers
primer
use
instead
oligo
dt
cdna
synthesi
cdna
level
quantifi
use
dynamo
color
flash
sybr
green
master
mix
rox
passiv
refer
dye
thermo
scientif
transcript
specif
primer
list
tabl
transcript
level
normal
viral
genom
quantifi
isol
dna
use
dneasi
blood
tissu
kit
qiagen
use
dilut
ng
bac
dna
gener
standard
curv
mrna
halflif
analys
hpi
actinomycin
sigma
ad
halt
transcript
rna
isol
indic
time
point
quantif
rtqpcr
use
taqman
reagent
appli
biosystem
primer
use
detect
probe
tcacacctatatctgtccaacccagcgaa
probe
ccaacctttggccacgcccc
list
tabl
final
primer
concentr
nm
probe
concentr
nm
use
primer
probe
use
describ
previous
gapdh
level
measur
use
taqman
rodent
gapdh
control
ribosom
rna
control
reagent
appli
biosystem
data
plot
rel
time
point
set
viral
supernat
collect
dpi
plate
cm
nih
mef
cell
infect
moi
centrifug
rpm
min
pellet
cellular
debri
subsequ
centrifug
sucros
cushion
rpm
h
pellet
viru
pellet
resuspend
pb
centrifug
continu
sucros
gradient
rpm
h
fraction
ml
collect
dna
extract
portion
fraction
use
dneasi
blood
tissu
kit
qiagen
quantifi
viral
dna
qpcr
use
gbspecif
primer
fraction
enrich
viral
genom
pool
pellet
centrifug
rpm
h
resuspend
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
nonidet
sd
western
blot
ammonium
bicarbon
mm
mass
spectrometri
cell
lysat
prepar
lysi
buffer
quantifi
bradford
assay
equival
amount
sampl
resolv
sdspage
western
blot
follow
primari
antibodi
hybridoma
supernat
antigb
dilut
kindli
provid
phillip
stevenson
univers
cambridg
dilut
kindli
provid
ren
sun
ucla
dilut
kindli
provid
linda
van
dyk
univers
colorado
denver
dilut
kindli
provid
moon
jung
song
korea
univers
primari
antibodi
follow
hrpconjug
goat
antimous
goat
antirabbit
secondari
antibodi
southern
biotechnolog
nih
cell
infect
measur
bind
measur
entri
min
moi
bind
assay
cell
wash
icecold
pb
scrape
dna
isol
dneasi
blood
tissu
kit
qiagen
entri
assay
cell
wash
pb
ml
citric
acid
mm
nacl
mm
kcl
mm
citric
acid
ph
ad
minut
rt
strip
remain
cell
surfacebound
viral
particl
cell
wash
twice
pb
scrape
dna
isol
rel
genom
level
quantifi
qpcr
gbspecif
primer
nih
mef
cell
grown
coverslip
infect
gfpbac
moi
hpi
coverslip
wash
pb
cell
fix
formaldehyd
min
rt
cell
permeabil
sodium
citrat
pb
min
incub
antibodi
goat
serum
hour
coverslip
wash
pb
incub
goat
antirabbit
secondari
antibodi
invitrogen
coverslip
wash
pb
mount
dapicontain
vectashield
mount
medium
vectorlab
stain
cell
nuclei
multistep
growth
curv
nih
mef
cell
infect
moi
supernat
cell
harvest
dpi
frozen
sampl
freezethaw
titer
plaqu
assay
nih
cell
vivo
experi
femal
mice
obtain
jackson
laboratori
bar
harbor
infect
week
old
inject
pfu
viru
ml
pb
periton
caviti
spleen
harvest
dpi
dna
isol
quantifi
qpcr
use
gbspecif
primer
determin
rel
level
viral
genom
qualiti
control
scale
experiment
crna
probe
valu
scale
refer
crna
probe
valu
wt
replic
determin
describ
compar
box
plot
use
r
packag
graphic
ignor
outlier
addit
scale
refer
crna
signal
subtract
scale
experiment
sampl
crna
signal
probe
normal
probe
valu
wt
replic
analyz
scatter
plot
linear
model
fit
scatter
plot
perform
use
lm
r
packag
stat
